DeepTek CXR Analyzer vs VX1+
AI Verdict
Choose DeepTek CXR Analyzer if…
Choose DeepTek CXR Analyzer if your radiology department handles a high volume of chest X-rays and aims to improve workflow efficiency and diagnostic accuracy. This FDA-cleared AI solution is ideal for automatically detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies, thereby assisting radiologists and potentially reducing their workload.
View DeepTek CXR Analyzer →Choose VX1+ if…
Choose VX1+ if you are an electrophysiologist seeking real-time AI-powered assistance during cardiac ablation procedures for atrial fibrillation or atrial tachycardia. This software is specifically designed to identify abnormal electrograms during the procedure, providing critical insights to guide ablation strategies and enhance procedural outcomes.
View VX1+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | DeepTek CXR Analyzer | VX1+ |
|---|---|---|
| Pricing | Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription. | Unknown |
| Deployment | On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment. | Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
DeepTek CXR AnalyzerDeepTek CXR Analyzer emphasizes seamless DICOM-based PACS integration and operates in the backend without altering existing radiology workflows, generating clear, color-coded AI outputs for easy interpretation. While VX1+ also offers a simple, color-coded user interface for real-time surgical assistance, DeepTek's focus on minimal workflow disruption for high-volume diagnostic environments gives it a slight edge in broader usability for its target audience.
Clinical Value
DeepTek CXR AnalyzerDeepTek CXR Analyzer is FDA-cleared and has demonstrated quantifiable improvements in diagnostic accuracy and efficiency in retrospective studies, reducing radiologist workload by 30-50% and boosting productivity by 2x-3x. Although VX1+ is also FDA-cleared and provides real-time AI insights during cardiac ablation, its FDA clearance explicitly states that the clinical significance of using the software to help identify areas for catheter ablation has not been established by clinical investigations. This distinction gives Tool A a stronger current claim to established clinical value.
Pricing & Value
DeepTek CXR AnalyzerDeepTek CXR Analyzer offers a transparent 'pay-per-use' pricing model and flexible service offerings (technology offering or AI-assisted reporting service), allowing customers to clearly understand and choose their cost structure. In contrast, VX1+'s pricing is not publicly available, making it impossible to assess its value proposition without direct inquiry.
Enterprise Readiness
DeepTek CXR AnalyzerDeepTek CXR Analyzer explicitly states HIPAA compliance and BAA availability, offers flexible cloud and on-premise deployment, and integrates seamlessly with PACS via DICOM. It has also been deployed as a national radiology AI platform. While VX1+ is FDA-cleared and integrates with specific EP systems, its HIPAA compliance and BAA availability are only 'expected' rather than explicitly stated in the provided information, giving Tool A a more robust enterprise readiness profile.
Innovation
VX1+VX1+ demonstrates greater innovation by providing real-time, AI-driven assistance to electrophysiologists during live, complex cardiac ablation procedures for identifying spatio-temporal dispersed electrograms. This intra-procedural decision support in a highly specialized and critical setting represents a more novel and advanced application of AI compared to DeepTek CXR Analyzer's diagnostic assistance for chest X-rays, even with its broad detection capabilities.
Support & Docs
TieBoth tools provide some level of documentation; DeepTek offers a 'Resources Hub' with white papers and installation guides, while Volta Medical explicitly mentions a 'User Manual' and 'Brochure' for VX1+. However, without more detailed information on the scope, accessibility, and responsiveness of their support services, it is not possible to definitively distinguish between the two on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | DeepTek CXR Analyzer | VX1+ |
|---|---|---|
| Name | DeepTek CXR Analyzer | VX1+ |
| Company | DeepTek Medical Imaging Pvt | Volta Medical |
| Primary Application | AI-powered CADe solution for chest X-ray analysis | AI-powered software to assist electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures |
| Key AI Functionality | AI-Powered Computer-Assisted Detection (CADe) for Chest X-rays; automatic detection and highlighting of suspicious regions | Real-time manual or automatic annotation of 3D anatomical and electrical maps of the human heart; identification of spatio-temporal dispersed electrograms (DEs) |
| Findings/Pathologies Detected | 28 findings covering lung, pleural, cardiac pathologies, and hardware | Spatio-temporal dispersed electrograms (DEs) during AF and AT procedures |
Videos
Demos, reviews, and walkthroughs featuring DeepTek CXR Analyzer and VX1+.